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GEN ‘RNA BUKAN PENGKOD PROTIN’ SEBAGAI SASARAN POTENSI 
UNTUK TUJUAN PENGESANAN DAN PEMBEZAAN Salmonella enterica 
serovar Typhi dan Salmonella enterica Serovar Paratyphi A DENGAN 
MENGGUNAKAN PCR 
 
ABSTRAK 
RNA-bukan-pengkod-protein (npcRNA) merupakan RNA yang tidak di 
terjemahkan kepada penghasilan protein. Sebaliknya, ia memainkan peranan dalam 
mengawal-atur pelbagai process dalam sel. Kebelakangan ini, ekspresi npcRNA tertentu 
telah dikaitkan dengan pelbagai penyakit manusia dan barah. Salmonellosis merupakan 
penyakit berjangkit yang disebabkan oleh bakteria, Salmonella spp melalui pengambilan 
makanan dan minuman yang tercemar. Pengesanan dan pembezaan antara Salmonella 
spp, termasuk S. Typhi dan S. Paratyphi A, adalah sangat penting untuk mengawal kadar 
jangkitan dan kematian. Oleh itu, keberkesanan dalam penyasaran gen-gen npcRNA 
untuk pengesanan dan pembezaan Salmonellosis telah dibincang dalam tesis ini, 
khususnya ujian multipleks PCR (mPCR) yang mengesan S. Typhi dan S. Paratyphi A 
secara spesifik telah dibangunkan. Had pengesanan ujian mPCR tersebut adalah 10pg. 
Selanjutnya, dalam eksperimen pencemaran S. Typhi dan S. Paratyphi A dalam najis, 
had pengesanan yang dicapai adalah 1.5 x 10
1
 dan 1.5 x 10
0
 CFU/mL selepas 4 jam 
inkubasi dalam media kultur “selenite cystine”. Secara lansung, ujian mPCR yang 
berasaskan npcRNA yang di bangunkan adalah sensitif dan spesifik untuk digunakan  
xvi 
 
dalam diagnostik klinikal dan pengawasan penyakit tersebut. Oleh itu, npcRNA 
mewakili sasaran molekul yang sangat baik untuk pengesanan penyakit salmonellosis. 
xvii 
 
NON-PROTEIN CODING RNA GENES AS THE POTENTIAL MARKERS FOR 
THE DETECTION And DIFFERENTIATION OF Salmonella enterica serovar 
Typhi and Salmonella enterica serovar Paratyphi A USING PCR 
 
ABSTRACT 
 Non-protein-coding RNAs (npcRNAs) are not translated into protein but are key 
regulatory molecules in the cell. Recently, the expression of specific npcRNAs has been 
linked to various human diseases and cancer. Salmonellosis is a communicable disease 
caused by members of the Salmonella species, which infect humans through 
contaminated food or water. It is of paramount importance that accurate detection 
methods are available for differentiating the Salmonella serovars that produce severe 
infection in humans, including S. Typhi and S. Paratyphi A. The efficacy of using 
npcRNA genes from S. Typhi as molecular targets in detection and differentiation of S. 
Typhi and S.Paratyphi A using a a multiplex polymerase chain reaction (mPCR) assay 
was reported in this study. The detection limit for this mPCR assay was 10pg of gDNA. 
Moreover, in a stool-seeding experiment with S. Typhi and S. Paratyphi A, a respective 
detection limit of 1.5 x 10
1
 and 1.5 x 10
0
 CFU/mL following 4h of enrichment in 
selenite cystine broth offers an early clinical diagnostics. Collectively, this study has 
successfully developed npcRNA genes based mPCR that is able to detect and 
differentiate S. Typhi, S. Paratyphi A in a typhoid infection besides discriminating them 
from a general salmonellosis. With its comparable specificity and sensitivity level to 
other studies/ products, this mPCR could prove to be an excellent alternative for clinical 
diagnosis and disease monitoring of salmonellosis. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Non-protein coding RNA  
Cells consist of two types of RNAs: 1) RNAs that are translated into proteins which are 
the messenger RNA (mRNA) and 2) RNA that are not translated into proteins but 
involved in many regulatory functions in the cell. They are often referred as small RNAs 
(sRNAs) as for short bacterial npcRNAs while non-coding RNAs (ncRNAs) have been 
the most common term for eukaryotic ncRNAs along with other synonyms such as 
functional RNAs (fRNAs) and to a lesser extent, non-messenger RNA (nmRNAs) 
(Eddy, 2001, Huttenhofer et al., 2002, Huttenhofer et al., 2005, Mattick, 2004). To have 
a common term for all such RNAs, we have opted to apply the term non-protein coding 
RNA (npcRNA) to all these functional RNAs, irrespective of the realm of life in which 
they might appear. 
 
 Recent advances in molecular biology have revealed vast range of npcRNAs in 
all three domains of life. For examples, Huttenhofer et al 2001 reported the 
identification of 201 npcRNAs from mouse brain (Huttenhofer et al., 2001, Mattick, 
2001), Tang et al 2002 identified 86 candidates for small non-messenger RNAs from the 
archaeon Archaeoglobus fulgidus and further reveals a the link between splicing of 
archaeal introns and rRNA processing in one of the candidate (Tang et al., 2002a, Tang 
et al., 2002b). npcRNA was also been reported from bacteria, for example, Vogel et al 
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disclosed the interaction of 2 npcRNAs in an antisense mechanism in Escherichia coli 
(Vogel et al., 2003). npcRNAs are reported to regulate the genes involved in the 
pathogenecity of the Vibrio cholerae and Mycobacterium tuberculosis which, contribute 
to their ability to cause disease and to survive, respectively (Arnvig and Young, 2012, 
Bardill and Hammer, 2012). 
 
The npcRNA participate in myriad of functions in a genome, i.e transcriptional 
regulation, post-transcriptional gene silencing, protein stability and mRNA stability 
(Flintoft, 2013, Kornienko et al., 2013, Mellor, 2010, Szymanski et al., 2003). Most 
npcRNAs seemed to fine-tune cellular responses during environmental changes by 
integrating environmental signals into global regulations. They act via mechanisms such 
as RNA-RNA base pairing, RNA-DNA base pairing, RNA-protein interaction and 
intrinsic RNA activity (Castello et al., 2013, Leontis and Westhof, 2001, Nacher, 2013, 
Rios, 2006). 
 
1.1.1 npcRNA as Biomarkers in Human Diseases and Cancer 
The differential expressions and tissue specificity has prompted npcRNA to be an ideal 
diagnostic markers in various human diseases and cancers (Lu et al., 2005, Ren et al., 
2013, Rosenfeld et al., 2008, Walley, 2013). For instances, the circulating miR-195 in 
blood has been found to be significantly elevated in breast cancer patients compare to 
healthy controls. Differential expression of miRNAs were also reported in patients with 
other malignancies such as colon, prostate, renal cancer (Heneghan et al., 2010a, 
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Heneghan et al., 2010b). Besides, circulating npcRNAs such as miR-1, miR-133, miR-
208 and miR-499 were observed to be significantly increased in plasma of acute 
myocardial infarction patients at early stage of the disease, notably, at 4
th
 hours of 
symptoms onset, thus they have been proposed to be an excellent markers for 
diagnostics (Ha, 2011, Kinet et al., 2013). 
 
1.1.2 npcRNA in Bacteria 
A plethora array of npcRNA candidates has been identified in bacteria by various 
experimental strategies (Brosius and Tiedge, 2004, Chinni et al., 2010, Heidrich et al., 
2006, Huttenhofer et al., 2002, Storz, 2002, Vogel et al., 2003, Washietl et al., 2005). 
Discoveries of growing numbers of npcRNAs have changed the previous impression that 
proteins are the only relevant players in bacterial gene expressions. Bacterial small 
npcRNAs usually constitute a structurally diverse class of molecules that are typically 
50-500 nucleotides in length. Besides lacking of an sizeable open reading frame (ORF) 
(Altuvia, 2007, Vogel et al., 2003) the majority of the known npcRNAs are found to 
have regulatory roles by base pairing with target mRNAs which theoretically, involve 
sequence-specific binding to a target RNA and therefore are referred to as antisense 
RNAs. The antisense RNAs in bacteria are divided into cis-encoded antisense RNAs and 
trans-encoded antisense RNAs.  
 
 Cis-encoded antisense RNAs are npcRNAs that perfectly complementary to their 
respective target and transcribed from the same locus, in an opposite orientation. By 
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contrast, trans-encoded npcRNAs are encoded by separate genetic loci. Trans-encoded 
npcRNAs are generally short and would exist in non-contiguous complimentarity to the 
target mRNA, therefore requires a chaperon protein such as Hfq to facilitate the binding 
in general (Jousselin et al., 2009, Vogel et al., 2003). 
 
 
 
Figure 1.1: The schematic diagram of both cis-encoded and trans-encoded antisense 
RNAs. Complexes formed by interaction between antisense and target RNAs are 
simplified (often, cis-encoded antisense/target RNA complexes are not fully paired). 
Non-contiguous helices are indicated in the right hand panels (adapted from Wagner et 
al., 2003). 
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1.1.2.1 Identification of Novel npcRNAs in S. Typhi 
Generally, the identification and characterization of npcRNA can be achieved via 
biocomputational or experimental. Notebly, the experimental RNomics has paid greater 
attention to the identification, classification, functional characterization and gene 
regulation of npcRNA in bacteria (Bartel, 2004, Huttenhofer et al., 2005, Papenfort and 
Vogel, 2010). By an experimental RNomic approach, Chinni et al., 2010 have 
discovered 97 novel npcRNAs candidates from the human pathogen Salmonella enterica 
serovar Typhi (S. Typhi), the causative agent of typhoid. Based on the location in the 
genome (Salmonella Pathogenicity Island-derived npcRNAs) and the differential 
expression of these npcRNA, the authors have proposed that some of the detected 
npcRNA candidate to be involved in regulatory mechanisms of virulence, antibiotic 
resistance and pathogenic specificity of S. Typhi. Interestingly, some candidates are 
thought to be specific to S. Typhi only and/or in Salmonella species.  
 
 However, further characterization, especially in the diagnostic potential of these 
npcRNA candidates, was not carried out. Therefore, this work looks into the potential of 
these npcRNA as molecular marker for the detection and differentiation of salmonellosis 
infection. 
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1.2 The Genus Salmonella and Its Characteristics  
In the year 1900, Lignieres coined the name Salmonella after Daniel Elmer Salmon, the 
bacteriologist who identified Salmonella Choleraesuis (S. Choleraesuis) in 1885 from  
pigs (Threlfall and Frost, 1990). The genus Salmonella is phylogenetically clustered in 
the family of Enterobacteriaceae (Chart, 2003). The salmonella is divided into 2 
species; S. enterica and S. bongori and has been assigned into more than 2500 different 
serovars (CDC,2011), which has been classified according to the Kauffman-white 
scheme based on the antigenic variation at lipopolysaccharide moieties – O antigen 
(somatic antigen), H antigen (flagellar antigen), and Vi antigen (capsular 
polysaccharides) (Brenner et al., 2000, Popoff et al., 2000, Schrader et al., 2008). 
 
 It is characterized as a gram-negative, ubiquitous, non-encapsulated, straight-rod 
shaped, facultative, non-spore forming, and generally motile with peritrichous flagella 
(Fig. 1.2) (McCarter, 2005), with the exception of the poultry-specific serovars, 
Salmonella enterica serovar Gallinarum (S. Gallinarum) and Salmonella enterica 
serovar Pullorum (S. Pullorum) (Ribeiro et al., 2009). The bacterium has a width of 0.7 
to 1.5 μm and a length of 2.0 to 5.0 μm (Holt et al., 1994). It can grow within a wide 
range of temperatures from 8 to 45°C, but the optimal growth temperature is within the 
range of 35 to 40°C (D'Aoust, 1991). Typically, Salmonella’s pH growth range lies 
within 4.5 to 9.0. However, the most favorable pH for growth is above 5.5 (Foster, 
1995). 
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 Salmonella are usually aerogenic - producing gas from glucose, and can utilize 
citrate as their sole carbon source. The failure to ferment lactose and the ability to 
produce Hydrogen sulphide (H2S) gas from Sulphur-containing amino acids are features 
used for the identification of Salmonella colonies on primary culture media. 
Nevertheless, S. Typhi is a facultative anaerobe, incapable of producing gas from 
fermentation of glucose, and does not utilize citrate (WHO 2000). The Salmonella 
bacterium is non-tolerant to oxidase and can convert nitrate to nitrite (Gilberthorpe and 
Poole, 2008, Vazquez-Torres et al., 2000) . 
 
 In addition, lysine and ornithine are decarboxylated and the bacterium do not 
hydrolyse urea nor deaminate tryptophan or phenylalanine (Viala et al., 2011,Wray 
2000). These unique characteristics provide a form of demarcation when identifying 
Salmonella from other closely related organisms. 
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Figure 1.2: The peritrechous flagellated Salmonella bacteria under the electron 
microscope (adapted from Eureka.com 2011). 
 
1.3 Salmonella enterica 
Salmonellosis is an infection caused by Salmonella spp which can be divided into two 
species, enteric and bongori, S. enterica can be subdivided into I) S. enterica subspecies 
enterica; II) S. enterica subspecies salamae; IIIa, S. enterica subspecies arizonae; IIIb) 
S. enterica subspecies diarizonae; IV) S. enterica subspecies houtenae and V) S. 
enterica subspecies indica These organisms are commonly, recovered from nearly all 
vertebrates, insects and environment (Choo et al., 2011, Gerlach and Hensel, 2007). 
However, the majority (99.5%) of isolated serovars from animal and human belongs to 
S. enterica subspecies I, thus, responsible for human salmonellosis (typhoidal and non-
typhoidal disease in human). Currently, there are over 2,300 serovars identified within 
subspecies with different prevalency and disease that they caused in different host. The 
clinical severity is largely based on the serovar affecting specific host (De Lappe et al., 
2009). 
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 The serovars have to overcome both the specific and non-specific host immune 
system during the course of adaptation. Thus, the pathogenecity of host adapted serovars 
results from the development of ways for the survival in host which is influenced by the 
genetic factor and environment in respective host (Uzzau et al., 2000). Among the S. 
enterica subspecies I that invades immune system of warm-blooded animals (Porwollik 
et al., 2004), S. Typhi is a well known serovar with its ability to modify the 
physiological function (such as intracellular engulfment, apoptosis, transfers of antigens 
by M cells and others) of the host for their conveniences (Gordon, 2008, Holt et al., 
2009, Spano et al., 2011). 
 
 Although, most of the serovars from subspecies I causes an acute, short duration 
localized gastroenteritis (or non-typhoidal salmonellosis in humans) rather than a 
systemic disease, such as Salmonella enterica serovar Typhimuruim and Salmonella 
enterica serovar Enteritidis (Asseva et al., 2012, Uzzau et al., 2000). However the 
human-restricted pathogen, S. Typhi and Salmonella enterica serovar Paratyphi A (S. 
Paratyphi A) causes severe systemic disease (typhoidal disease in humans) presented as 
septicemia, fever, severe diarrhea and could be life-threatening (Gal-Mor et al., 2012). 
 
 Therefore, Salmonella enterica subspecies enterica especially S. Typhi and S. 
Paratyphi A, are the most pathogenic subspecies of Salmonella genus with highest 
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medical significance. Therefore, these subspecies deserve for greater clinical attention 
compare to other subspecies. 
 
1.4 Pathogenesis of S. Typhi 
S. Typhi (and S. Paratyphi A) causes enteric fever, acquired through fecal-oral ingestion 
leading to systemic infection. However, least observation has been made on the 
pathogenesis of typhoid as the host-range of S. Typhi and S. Paratyphi A restricted to 
human. Experimentation using S. Typhimuruim and surrogate host (mice) convey that 
invasion of S. Typhi occurs through M cells on peyer’s pathches (Figure 1.3). S. Typhi 
will finally localize to the bone marrow and ended-up at gall bladder where the internal 
transmission cycle is completed where the organisms are shed in bile, probably in high 
numbers. S. Typhi (but not S. Paratyphi A) expresses the Vi capsular polysaccharides, 
which possesses immuno-modulatory properties that capable to overcome host immune 
defenses profoundly (Gordon, 2008, Holt et al., 2009, Spano et al., 2011, Wain et al., 
1998, Wain et al., 2001). 
 
  Thus, S. Typhi probably appreciates a simple default pathway by limiting the 
activation of inflammatory response which results in the lacking of gastroenteritis 
symptoms at early stage of invasion. Moreover, human do not react clinically to the 
initial invasion step since there is an incubation period before the emergence of the 
symptoms, which usually occur during the phase of systemic infection. Therefore, an 
early diagnostics as soon as symptoms emerge could help to control the rate of  
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morbidity and mortality of the disease. A disease symptom that is indistinguishable from 
typhoid infection clinically is an additional caveat for an effective and appropriate early 
diagnostics (Raffatellu et al., 2005a, Raffatellu et al., 2005b). 
 
Figure 1.3: The life-cycle of S. Typhi in human host. A) S. Typhi usually enters the 
human through fecal-oral ingestion of an infectious dose. B) S. Typhi enters large 
intestine, at this stage host may shed the organism in the stool in sporadic or limited 
amount as S. Typhi do not replicate in large intestines. C) Invasion of S. Typhi through 
the terminal ileum probably via the M cells, this perhaps takes place a short time after 
ingestion. D) S. Typhi will be trafficked to the reticulo-endothelial system via monocytic 
cells, potentially in semi-dormant state. E) Upon the activation of acquired immune 
response, S. Typhi re-emerges from the reticulo-endothelial system and re-enters the 
blood stream in low numbers. F) S. Typhi seeds into liver, the gall bladder, and the bone 
marrow where it can reside and may be detected for months or years. G) S. Typhi 
capable of entering into the bile duct and shedded in high numbers into the environment 
via intestines. H) Excretion of S. Typhi in stool (Baker et al., 2010). 
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1.5 Typhoid and Diagnostics  
Typhoid fever is the global problem that claims thousands of lives yearly. Infants, 
childrens, elderly people and immuno-compromised patients are at high risk (WHO, 
2005). However, estimation of typhoid is difficult as only severe cases are ever reported. 
Awareness in the rising incidence of the disease, such as paratyphoid infections is 
important for the improved control of the disease. Therefore, an accurate diagnostics is 
not only important for the treatment but also plays an important role in disease vigilance 
(Teh et al., 2008). 
1.5.1 Global Burden of Typhoid  
Globally S. Typhi and S. Paratyphi A account for more than 21.7 million and 5.4 million 
infections per year, respectively (Crump et al., 2004), with highest incidence being 
reported in developing and under-developing countries in South–East Asia, representing 
394.2 cases per 100,000 populations (Buckle et al., 2012). Typhoid strike Malaysia with 
sporadic outbreak from time to time with an incidence rate of 0.84 per 100,000 (MOH, 
2012). However, this rate is predicted to raise due to the emergence of foreign workers 
from endemic neighbouring countries such as Indonasia and India (Baker et al., 2008, 
Holt et al., 2012). 
 
Epidemiologically, typhoid fever has been superseded by paratyphoid infection 
(Ochiai et al., 2005), which is now responsible for 30–50% of enteric fevers in South–
East Asia, particularly in the countries with largest population, China and India (Maskey 
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et al., 2008). Unfortunately, there is no current paratyphoid vaccine, and administration 
of S. Typhi vaccine provides little to no protection against S. Paratyphi A (Pakkanen et 
al., 2014, Pokharel et al., 2006, Sahastrabuddhe et al., 2013, Tankhiwale et al., 2003). 
Moreover, paratyphoid has become increasingly prevalent among vaccinated travelers, 
and these has  pose a threat to developed countries as well (Connor and Schwartz, 2005). 
Therefore, there is a requisite rapid diagnostic test for clinical management, contact 
tracing, and identification of convalescent/chronic fecal carriers. 
  
1.5.2 Tradisional Diagnostics of Typhoid 
Current diagnostic of typhoid infection depend on isolation of organisms from patient, 
most commonly blood culture and the serological based test (Wain and Hosoglu, 2008). 
An obvious obstacle in blood culturing during the early stage of infection will be the low 
number of bacteria in the blood that might lead to false negativity. There are situation 
where high number of bacteria present in ‘unculturable’ form, for example, the rapid 
transfer of bacteria in dormant form from within an intracellular vacuole to laboratory 
media may kill the fastidious and delicate organisms (Baker et al., 2010). Besides that, it 
takes about 3-5 days to obtain the results. 
 
 Widal test is a crude assay that monitors agglutinating antibodies that react with 
S. Typhi. Since S. Typhi is a member of the Enterobactericae, where many of the 
surface antigens demonstrates significant conservation and induce antibodies that are 
cross-reactive. Besides, individuals in endemic areas have cross-reactive antibodies even 
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though they have no clinical record of typhoid, thus any such serological based test 
would likely to yield a significant false-positive result (Baker et al., 2010, House et al., 
2005, House et al., 2001). 
 
1.5.3 PCR-based Diagnostics of Typhoid 
The advancement in molecular techniques adopted Polymerase Chain Reaction (PCR) 
during the urgent raise for the rapid, sensitive and specific diagnostic of typhoid. PCR is 
capable of amplifying small fragment of DNA into thousands of copies, ensuring the 
rapid detection of the organism at early stage of an infection without the expense of 
sensitivity and specificity. Food industry has used PCR for several decades and 
published a standardized guidelines for the detection of Salmonella in food samples 
(Malorny et al., 2008), while there are several studies that are looking into specific 
detection of S. Typhi from clinical sample . 
 
 Current PCR-based assays for diagnosing typhoid or salmonellosis have been 
largely based on the detection of protein-coding genes and 16S rRNA. For example, 
multiplex PCR was designed based on O, H and Vi antigen genes for the rapid detection 
of S. Typhi and S. Paratyphi A (Hirose et al., 2002). Elsewhere, Aziah et al have 
reported the usage of ~50kDa channel protein gene as the target for the specific 
detection of S. Typhi (Aziah et al., 2007). Additionally, Ngan and coworkers have 
developed a multiplex PCR based assay for the precise detection of Salmonella spp, S. 
Typhi and S. Paratyphi A by targeting outer membrane protein gene, putative protein 
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gene and fimbrial protein gene (Ngan et al., 2010). Recently, Thong and Chua have 
patented a specific detection of Salmonella spp., S. Typhi and S. Paratyphi A based on 
protein-coding genes (Thong & Chua 2013). Besides protein-coding genes, 16S rRNA 
which is highly conserved in all bacteria, have also been used for the detection of S. 
Typhi (Woo et al., 2001, Zhu et al., 1996). 
 
Recently, the specificity and stability of npcRNAs as biomarkers in various 
human diseases and cancer have suggests that these molecules may serve as an excellent 
molecular target for the detection of infectious diseases such as salmonellosis.  
 
1.6 Research Objectives 
 Feasibility of npcRNA genes as target in multiplex PCR could provide an alternate 
choice for the specific and sensitive detection of Salmonella spp., S. Typhi and S. 
Paratyphi A. Therefore, the objectives of this project were; 
 
1. To identify npcRNA genes that is specific tor S. Typhi, S. Paratyphi A and Salmonella 
species for the PCR primers design. 
2. To optimize multiplex PCR assay for the detection and differentiation of S. Typhi, S. 
Paratyphi A and Salmonella species  
3. To estimate the sensitivity and specificity of multiplex PCR. 
4. To evaluate the sensitivity and specificity of the developed multiplex PCR in seeded 
stool sample. 
  
CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Materials  
2.1.1 Chemicals and Reagents  
All the chemicals were of analytical grade. Chemicals and reagents used in this study are 
listed below in alphabetical order according to the manufacturer’s name. 
 
Manufacturer  Chemicals   
Amresco  
 
Bio basic inc (Canada) 
Bio-Rad (Hercules,USA)  
 
Biotools (Canada)  
 
Laborotarious Conda  
(Madrid,Spain)  
Invitrogen 
® 
(Carlsbad,CA) 
Merck KGaA (Darmstadt, 
Germany 
Promega (Madison,USA) 
Sigma 
                                      
Sodium acetate; Sodium hydroxide; 
Potassium chloride anhydrous. 
EDTA; PCR primers. 
Chelax; Ethidium bromide (10mg/mL);  
Sodium deodecyl sulfate (SDS) 
10X PCR buffer; Magnesium chloride ; 
DNTP mix; DNA polymerase. 
LB agar (lennox); LB broth (lennox); Mac 
Conkey 
Ultra-pure Tris 
Ethanol; Acetic acid (glacial) 100%; 
Sodium hydroxide; Glycerol 
100bp DNA ladder; Agarose 
XLD agar; selenite cystine broth. 
 
 
 
 
 
 
2.1.2 Buffers/Solutions  
Buffers/solutions together with their components used in this study are listed below in 
alphabetical order. 
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Manufacturer  Chemicals   
5X loading dye (Orange Dye)     
 
10X PBS buffer   
 
10X TAE buffer  
 
 
 
Buffer for Genomic DNA extraction 
1) Solution I  
 
 
2) Solution II  
 
3) Solution III                               
4) Solution IV                               
                                      
6.75 g of Ficoll; 0.25 g orange G; dissolve in 
ddH2O by heating.    
80 g NaCl; 2.0 g KCL; 14.4 g of Na 2HPO 4; 
2.4 g KH2PO4  in 1L of ddH2O pH 7.4. 
242 Tris base; 57.1mL Acetic acid; 100 mL 
0.5 M EDTA, adjust pH to 8.5, add ddH2O to 
final volume of 1 L. 
 
 
Dissolve 20 % sucrose, 50 mM Tris-Hcl, pH 
8.0, 1% SDS, 0.2M Sodium hydroxide, 25 
mM EDTA, pH 8.0 and 0.1 M NaCl. 
3M Sodium acetate, pH 6.4 (pH adjusted 
using glacial Acetic acid). 
95% Ethanol 
3 M sodium acetate, pH 5.2 (pH adjusted 
using glacial Acetic acid).              
    
 
 
 
 
 
 
 
2.1.3 Bacteria Strains 
Strains Origin/Reference 
Salmonella enterica Serovar       
 
 
Typhi 
Paratyphi A 
Paratyphi C 
Department of Microbiology & 
Parasitology, School of 
Medical Sciences, 
Universiti Sains Malaysia 
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Pullorom 
Jawa 
Kedougou 
Mikawashima 
Give 
Hadar 
Corvalis 
Bareily 
Newport 
Agona 
Tennessee 
Typhimuruim 
Weltevreden 
Enteritidis 
Albany 
Paratyphi B 
Braenderup 
Infantis 
 
 
 
 
 
Veterinary Research Institute 
Ipoh,Malaysia 
Non-Salmonella strains 
 
Klebsiella pneumonia 
Pseudomonas aeruginosa 
Esherichia coli  
Shigella flexnari 
Vibrio cholera 
Acenitobacter baumanii 
Aeromonas hydrophiila 
Neisseria meningitides 
Streptococcus spp. 
Staphylococcus epidermis 
Providencia spp. 
 
 
 
 
Clinical Trial Centre, 
Advanced Medical and Dental 
Institute, 
Universiti Sains Malaysia 
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2.1.4 Plasmid 
 
2.1.5 Culture Media  
Culture media Ingredients Manufacturer 
LB agar (lennox)  
 
 
LB broth (lennox) 
 
 
Mac conkey 
 
 
 
 
Selenite cystine broth  
 
 
 
 
 
XLD agar 
 
Trypton 10 g; yeast 
extract5g;NaCl 5g; 
bacteriological agar 15 g; 
ddH2O to 1 L. 
 
Trypton 10g;Yeastextract 
5g;NaCl5g;Bacteriological 
agar 15g; ddH2O to 1L. 
Peptone 17g; Proteose 
Peptone 3g; NaCl 5g; 
Cystal violet 1mg; Neutral 
red 30 mg; Bile salts 1.5 g; 
Bacteriological agar 13.5 
g; ddH2O to1 L 
 
Sodium phosphate 10g; 
Peptone mixture 5 g; 
Lactose 4 g; Sodium 
selenite 4 g; L-cystine 0.01 
g; ddH2O to 1 L. 
 
Yeast extract 3 g; Lactose 
7. 5g; Sucrose 7.5 g; 
Xylose 3.5 g; L-lysine 5 g; 
Ferric Ammonium Citrate 
0.8 g; Phenol red 0.08 g; 
 
Laborotorious conda 
(Madrid,Spain) 
 
 
Laborotorious conda 
(Madrid,Spain) 
 
Laborotorious conda 
(Madrid,Spain) 
 
 
 
 
Sigma Aldrich (Missouri. 
USA) 
 
 
 
 
Laborotorious conda 
(Madrid,Spain) 
Plasmid Origin/References 
 pL50 (Seegene, USA)                                Forever 100bp ladder personalizer 
Gene information: c
-
myc gene isolated 
from mouse  
Imprinting gene region tissue. 
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Sodium chloride 5 g; 
Sodium deoxycholate 2.5 
g; Sodium thiosulfate 6.8 
g; Bacteriological agar 
13.5 g; ddH2O to 1 L 
 
2.2 Methods 
2.2.1 Bacteria growth  
Single colony of bacteria aforementioned in section 2.1.3 was inoculated into 10 mL of 
LB broth (Lennox) and incubated at 37ºC at 200 revolutions per minute (rpm) for 16 
hours (h) to produce fresh overnight culture.  
 
2.2.2 Bacterial Culture Storage Conditions 
For short-term storage, fresh culture was streaked onto LB agar/Mac Conkey incubated 
for 16 h at 37°C to obtain single colonies and the culture was sub-cultured every 2 
weeks. For longer storage, glycerol was aseptically added to reach final concentration of 
20% v/v to 200 µL of overnight bacterial culture stored at -80C. In case of revival the 
100 µL of glycerol stock will be added into 10 mL of LB broth. 
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2.2.3 Bacterial Isolates 
Twenty-two Salmonella species and 15 other bacterial strains (Gram-negative and 
Gram-positive) were obtained from the Veterinary Research Institute, Clinical trial 
centre, Advanced Medical and Dental Institute (AMDI) and Department of Medical 
Microbiology and Parasitology, School of Medical Science, University Sains Malaysia, 
Kelantan (Section 2.3.1). 
 
2.2.4 Bacterial Genomic DNA Extraction 
 Genomic DNA extraction was performed using an in-house protocol. In brief, the 
bacterial strains were cultured in Luria–Bertani (LB) broth for 16 h (37C, 200 rpm). 
Subsequently, 1.5 mL of each culture was centrifuged (Kubota, Japan) at 13,000 rpm for 
1 minute (min), and the supernatants were discarded. The pellets were resuspended in 
200 L of Solution I, which was followed by addition of 200 L of Solution II. The 
tubes were gently inverted, incubated for 5 min at room temperature, and centrifuged 
(13,000 rpm, 5 min). The supernatants were transferred to fresh tubes. One mL of 
solution III was added to each tube, followed by 40 L of solution IV (pH 5.2). The 
tubes were then incubated at –80C for 20 min and centrifuged (13,000 rpm at 4C, 13 
min). The supernatants were discarded. The pellets were washed with 1 mL of 70% 
Ethanol, air-dried, and dissolved in 50 L autoclaved distilled water. The concentration 
of bacterial DNA was measured using UV spectrophotometer (Eppendorf, Germany). 
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2.2.5 Multiplex PCR (mPCR) Amplification 
PCR parameters were optimized and amplification was performed in 20 L reaction 
volume, which contained the following: 5 pmol of each forward and reverse primer for 
StyR-3, StyR-36, StyR-143, and pL50; 200 M dNTPs; 3 mM MgCl2; 2 U Taq DNA 
polymerase in 1X PCR buffer. For template DNA,  1 L (100 ng) of genomic DNA 
extracted from bacterial cultures or 2 L of DNA extracted from spiked stool samples. 
PCR was performed in a Bio-Rad thermocycler (Bio-Rad, USA) with an initial 
denaturation at 95C for 1 min, followed by 30 amplification cycles (30 seconds (s) 
denaturation at 95C, 30 s annealing at 66C, 30 s extension at 72C), and a final 
elongation of 2 min at 72C.  
 
2.2.6 PCR Product Analysis 
The PCR products were analyzed by electrophoresis using a 2% agarose gel in TAE 
buffer containing 0.5 g/mL of Ethidium bromide. The PCR reaction products (20 L) 
were electrophoresed at 60 V for 60 min and visualized using a gel-imaging system 
(Bio-Rad, USA). 
 
2.2.7 Specificity of the mPCR Assay  
Thirty-seven (37) bacterial strains genomic DNA from different sources (Section 2.1.3)  
were used to assess the analytical specificity of the optimized mPCR assay. One hundred 
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(100) ng of genomic DNA of each Salmonella and other bacteria strains was subjected 
to PCR. Specificity were confirmed through the amplification of target organisms. 
 
2.2.8 Sensitivity of the mPCR Assay 
The analytical sensitivity represents the lowest concentration of template DNA that can 
be amplified to produce visible bands upon gel electrophoresis. 
 
2.2.8.1 Sensitivity of the mPCR using Genomic DNA 
 To determine sensitivity of the assay, genomic DNA from S. Typhi, S. Paratyphi A, and 
S. Paratyphi B (i.e. non-S. Typhi and non-S. Paratyphi A) was extracted (Section 2.2.4) 
and serially diluted 10-fold from 100 ng to 1 pg. The lowest concentration that produces 
amplicon will be regarded to be ‘detection limit’ of the assay. 
 
2.2.8.2 Sensitivity of the mPCR using Spiked Human Stool Sample 
An artificial stool contamination experiment (stool spiking) was carried out based on a 
method described by Kongmoung, with slight modification (Kongmuang et al., 1994). 
Single colonies of S. Typhi and S. Paratyphi A were inoculated and grown overnight in 
LB broth. The bacterial cultures were adjusted to 0.5 MacFarland turbidity standard 
which is used to standardize the approximate number of bacteria in a liquid suspension 
by visually comparing the turbidity of suspension with MacFarland standard value. 
Turbidity of bacteria cell suspension were adjusted to 0.132 at OD600 which is equivalent 
to 1.5 x 10
8 
CFU/mL, using UV spectrophotometer,. A ten-fold serial dilution was 
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performed (1.5 x 10
8 
CFU/mL to 1.5 x 10
0 
CFU/mL), and 1 mL of each dilution was 
spiked into 0.2 g of healthy human stool (confirmed to be Salmonella negative through 
culturing). The infected feces were then mixed with 9 mL of selenite cystine broth. The 
spiked stool samples (before and after enrichment) were processed for PCR 
amplification. In brief, 1.5 mL of each spiked stool sample was centrifuged (13,000 rpm, 
1 min). The supernatants were then discarded, and the pellets were washed with 500 L 
of 0.01 M phosphate-buffered saline (PBS). After resuspension with PBS, the samples 
were centrifuged (13,000 rpm, 10 min), and the supernatants were again discarded. The 
pellets were then resuspended in 50 L of 10% chelex and boiled for 10 min. Following 
centrifugation (13,000 rpm, 15 min), 2 L of each of the supernatants was used as 
template in the mPCR assay. The lowest CFU/mL that produces amplicon will be 
regarded to be ‘detection limit’ of the assay. 
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CHAPTER 3 
 RESULTS 
 
3.1 Selection of the npcRNA Gene Candidates as Diagnostic Markers in mPCR 
Assay.  
StyR-3, StyR-36 and StyR-143 are the specific npcRNAs that was experimentally 
identified in the genome of S. Typhi (Table 3.1). StyR-3 was reported to be present in 
Salmonella spp., StyR-36 was specific to S. Typhi and StyR-143 was found to be specific 
for both S. Typhi and S. Paratyphi A. Therefore, mPCR amplification was carried out 
targeting these npcRNA genes which were predicted to participate in the pathogenecity 
of Salmonella (Chinni et al., 2010). 
 
Table 3.1: The sequence of npcRNA candidates 
npcRNA 
candidates 
Sequence (5 - 3’) 
 
StyR-3 
 
 
 
StyR-36  
 
 
 
 
StyR-143 
 
TTACTCACTCATAATCAAGGGCTGCCGCATGAAGTGGTAGAAAAGCAT
ATTGCAGGCCATGCGATAAGCCGTCTCACAATTTGTGTGGTTATTACTA
TGCTTATTGCTGTTGCCGTAAATGTGCGGTGCGGGAGCCGCTGACGA 
 
CCATGCGCTTGCGCTAAGAGACGTCAGGTATCTATGGAGGAACAAGTT
ATGGATACAAACGAACTTGGCTTAGTTAAGGCGCGTGTTGAACTGATC
ACCGCTATGCTCAAATGCGCAACCGCGTTTGTTGGCTTAGTTGGTGCGG
TTTACGCCGTTCTTAACATGGCCTTCAACT 
 
ATTCTTACTCAAAAAGACAAGGGAGGAATGCCGCAAGAAACCAAAGA
AAATCATGGGTTTCATTAAACTTCATTATTGAAGAGGTTTAATAAAGCT
GGTTCTATAGGTGCGCGCCTGCTCGTCTTTCATTGTGCCAGCTTTTCT 
 
